Pre-launch insight to Torx™, a new platform for small molecule discovery chemistry
Read full press release
Cambridge, UK – March 24th, 2015 – Cresset, innovative provider of computational chemistry software and services, is pleased to announce that Mercachem, a leading European contract research organization, has chosen Cresset’s Torch and Spark software to support their growing medicinal chemistry service business. Torch is a molecular design and SAR analysis application. Spark is a powerful bioisosteric replacement tool which is excellent for generating new chemical ideas for your project.
“Mercachem delivers outstanding discovery and medicinal chemistry on a contract basis to global clients,” says Dr Gerhard Müller, Senior Vice President Medicinal Chemistry at Mercachem. “Computational tools are an essential part of our workflow and we are confident that Torch and Spark will make a significant contribution to our lead finding and optimization projects. We particularly like the diversity of results that Spark delivers. We find that it identifies new, unexpected structures with high inspirational potential for the design of next-generation compound series, and as such, this provides true value to our work and to our clients.”
“Molecular design software is no longer the sole preserve of computational chemists,” says Cresset’s Commercial Director, Dr David Bardsley. “We are delighted that leading contract research organizations such as Mercachem are investing in Cresset’s innovative and easy to use software tools for medicinal chemistry.”